Meet an Unreasonable Venture

Epoch Biodesign

Using AI-designed enzymes to enable infinite recycling of mixed plastics and textiles.

Jacob Nathan

Founder & CEO at Epoch Biodesign

More about Jacob »

Connect

epochbiodesign.com

Employees 21–50

Headquarters United Kingdom

Epoch Biodesign develops enzymatic processes to recycle plastic and textile waste, starting with nylon. Using AI-driven synthetic biology and materials science, it breaks plastics down into high-purity chemical building blocks for reuse. Based in London, Epoch operates at lab scale, with a demo facility targeting 150 metric tonnes annually in 2025. Long term, it aims to license and operate its technology globally, driving scalable circularity.

Energy & Environment

Notable Achievements

Raised more than $50M from investors including Lowercarbon Capital, Inditex, and Extantia.
Working with over 30 leading brands to develop and scale circular textile solutions.
Built a world-class team of 30 biochemists, process engineers, and ML scientists.

Currently Operating in One Region

Press Mentions

February 9, 2026

Invista and Epoch partner on enzymatic nylon recycling

Epoch Biodesign partners with Invista to develop an innovative enzymatic recycling process for nylon, aiming to enhance sustainability in the textile industry. This collaboration highlights Epoch...

Read on Knitting Trade Journal »

August 28, 2025

10 AI Applications Shaping the Future

Epoch Biodesign has emerged as a pioneering company in sustainable biotechnology. Their innovative approaches to biodesign are driving positive environmental impacts, showcasing their commitment to...

Read on TIME.com »